Percutaneous coronary intervention and Swallowing difficulty
Summary:
Swallowing difficulty is found among people with Percutaneous coronary intervention, especially for people who are male, 60+ old.
The study analyzes which people have Swallowing difficulty with Percutaneous coronary intervention. It is created by eHealthMe based on reports of 13 people who have Percutaneous coronary intervention from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Percutaneous coronary intervention?
Percutaneous coronary intervention is found to be associated with 40 drugs and 131 conditions by eHealthMe. Check the latest studies of Percutaneous coronary intervention.
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 2,401 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.
13 people who have Percutaneous Coronary Intervention and Swallowing Difficulty are studied.

Gender of people who have Percutaneous Coronary Intervention and experienced Swallowing Difficulty *:
- female: 46.15 %
- male: 53.85 %
Age of people who have Percutaneous Coronary Intervention and experienced Swallowing Difficulty *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 75 %
Common co-existing conditions for these people *:
- Hospitalisation: 3 people, 23.08%
- Heart Attack: 3 people, 23.08%
- Coronary Artery Thrombosis (clot formation in coronary artery): 2 people, 15.38%
- Wound: 1 person, 7.69%
- Enlarged Prostate: 1 person, 7.69%
- Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 7.69%
- Anaemia (lack of blood): 1 person, 7.69%
- Bone Pain: 1 person, 7.69%
- Conjunctivitis (pink eye): 1 person, 7.69%
- Constipation: 1 person, 7.69%
Common drugs taken by these people *:
- Heparin: 4 people, 30.77%
- Clopidogrel: 3 people, 23.08%
- Aspirin: 2 people, 15.38%
- Bivalirudin: 2 people, 15.38%
- Eptifibatide: 2 people, 15.38%
- Zyrtec: 1 person, 7.69%
- Cytoxan: 1 person, 7.69%
- Lopressor: 1 person, 7.69%
- Levaquin: 1 person, 7.69%
- Leukine: 1 person, 7.69%
Common symptoms for these people *:
- Weakness: 6 people, 46.15%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 38.46%
- Nausea (feeling of having an urge to vomit): 5 people, 38.46%
- General Physical Health Deterioration (weak health status): 5 people, 38.46%
- Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 5 people, 38.46%
- Transaminases Increased: 4 people, 30.77%
- Diarrhea: 4 people, 30.77%
- Confusional State: 4 people, 30.77%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 30.77%
- Inflammatory Marker Increased: 4 people, 30.77%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Swallowing difficulty?
- Check whether Swallowing difficulty is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Percutaneous coronary intervention (3,993 reports)
- Swallowing difficulty (112,312 reports)
All the drugs that are associated with Swallowing difficulty:
- Swallowing difficulty (2,401 drugs)
All the conditions that are associated with Swallowing difficulty:
- Swallowing difficulty (3,350 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Swallowing difficulty and Percutaneous coronary intervention, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ferrous Fumarate and Doxorubicin Hydrochloride - 4 seconds ago
- Drug interactions of Kenalog and Effexor - 14 seconds ago
- Drug interactions of Phenytoin Sodium and Rabeprazole Sodium - 14 seconds ago
- Drug interactions of Sitagliptin Phosphate and Niaspan - 18 seconds ago
- Could Anzemet cause Cervical Dysplasia? - 20 seconds ago
- Drug interactions of Diprivan and Singulair - 36 seconds ago
- Drug interactions of Asacol Hd and Lyrica - 38 seconds ago
- Could Iron Dextran cause Gingival Disorder? - 42 seconds ago
- Could Amoxicillin cause Fibrous Histiocytoma? - a minute ago
- Drug interactions of Sinemet Cr and Apomorphine Hydrochloride - a minute ago